GSA Capital Partners LLP Acquires New Holdings in Quanterix Co. (NASDAQ:QTRX)

GSA Capital Partners LLP acquired a new stake in shares of Quanterix Co. (NASDAQ:QTRX) during the third quarter, HoldingsChannel reports. The fund acquired 19,934 shares of the company’s stock, valued at approximately $258,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in QTRX. nVerses Capital LLC bought a new position in Quanterix during the third quarter valued at approximately $60,000. SG Americas Securities LLC bought a new position in Quanterix in the third quarter worth approximately $139,000. Canada Pension Plan Investment Board bought a new position in Quanterix in the second quarter worth approximately $140,000. Hsbc Holdings PLC raised its position in Quanterix by 34.7% in the second quarter. Hsbc Holdings PLC now owns 12,738 shares of the company’s stock worth $164,000 after acquiring an additional 3,279 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its position in Quanterix by 11.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 14,261 shares of the company’s stock worth $188,000 after acquiring an additional 1,417 shares during the period. Institutional investors own 86.48% of the company’s stock.

Quanterix Trading Up 0.3 %

QTRX stock opened at $11.75 on Friday. Quanterix Co. has a 12 month low of $10.50 and a 12 month high of $29.70. The company has a 50-day moving average price of $12.86 and a 200 day moving average price of $13.79. The stock has a market cap of $450.97 million, a PE ratio of -11.19 and a beta of 1.36.

Analysts Set New Price Targets

Several brokerages have recently commented on QTRX. TD Cowen raised their price objective on shares of Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a research report on Wednesday, November 13th. Scotiabank cut their target price on shares of Quanterix from $32.00 to $28.00 and set a “sector outperform” rating for the company in a research note on Monday, August 12th.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.